MIT researchers have built a nano - scale, drug - producing factory that could
provide precision cancer tumor - killing inside your body.
Not exact matches
«Pathologists who specialize in molecular diagnostics and lung
cancer collaborated to create the guideline to minimize variation and
provide greater
precision in the care of patients.»
In an era of
precision medicine, the guideline
provides recommendations for pathologists, oncologists, and other
cancer health professionals on the current state - of - the - art recommendations for the molecular testing of lung
cancer.
«Once the ovarian
cancer becomes drug resistant we can not cure it,» says Rodriguez a gynecologic oncologist who provides treatment to ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New J
cancer becomes drug resistant we can not cure it,» says Rodriguez a gynecologic oncologist who
provides treatment to ovarian
cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New J
cancer patients and is director of the
precision medicine initiative at Rutgers
Cancer Institute of New J
Cancer Institute of New Jersey.
Professor Tim Maughan, Clinical Director of the
Cancer Research UK / Medical Research Council Oxford Institute for Radiation Oncology, said «This novel and exciting finding
provides a new scientific basis for
precision targeting of some
cancers which are currently very difficult to treat, and we are now taking these findings into clinical trials.»
This new commitment to the
precision medicine initiative will
provide additional opportunities over the next three years for physicians to analyze the genomic profiles of pediatric patients to better understand their
cancers and help improve treatment options.
«In identifying a specific abnormality in a patient's
cancer instead of the overall organ where it first presented, the opportunity exists to provide tailored therapies for patients,» notes Lorna Rodriguez, MD, PhD, director of the precision medicine initiative at the Cancer Institute and professor of obstetrics, gynecology and reproductive sciences at Robert Wood Johnson Medical S
cancer instead of the overall organ where it first presented, the opportunity exists to
provide tailored therapies for patients,» notes Lorna Rodriguez, MD, PhD, director of the
precision medicine initiative at the
Cancer Institute and professor of obstetrics, gynecology and reproductive sciences at Robert Wood Johnson Medical S
Cancer Institute and professor of obstetrics, gynecology and reproductive sciences at Robert Wood Johnson Medical School.
We
provide access to the latest medicines and technology, as well as the most advanced clinical trials including novel personalized targeted therapies including
precision medicine and immunotherapy - some that are only offered at NCI - designated Comprehensive
Cancer Centers like ours.
Cancer researchers are increasingly using advanced technologies that are capable of
providing far more information and detail than was previously possible, propelling the shift toward
precision medicine.
A new multicenter trial focuses on
providing precision treatments for rare
cancers based on genetics, not tumor site.
For example, the translational laboratory is
providing support to a
precision medicine - based clinical trial for patients with early - stage, triple - negative breast
cancer.